However, as indicated by the results presented above, FoxOs (and Sox2) may be required for functional stemness and post-treatment survival mainly in p53-proficient (see Figure 5B, 5C), but not in p53-deficient (see Figure 5G, 5H), GBM-SCs. This evidence concerns the gene SOX2 and glioblastoma.